Afton Scientific, LLC

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Afton Scientific, LLC - overview

Established

2004

Location

Charlottesville, VA, US

Primary Industry

Pharmaceuticals

About

Founded in 2004 and based in Virginia, US, Afton Scientific, LLC operates as a contract manufacturing organization that specializes in sterile injectables for liquid vial filling, terminal sterilization, labeling, and packing for the pharmaceutical industry. The company was founded by its CEO, Tom Thorpe. In January 2024, Arlington Capital Partners acquired a majority stake in Afton Scientific, LLC. The company focuses on small-batch commercial products and clinical trials, providing sterile filling for suspensions, mRNA, monoclonal antibodies, and other biologics.


The firm’s services include lab support, with Quality Control Analytical and Microbiology Labs handling projects from start to finish. The January 2024 acquisition helps the organization to accelerate its growth as well as expand its service offerings internationally.


Current Investors

Arlington Capital Partners

Primary Industry

Pharmaceuticals

Sub Industries

Medical Supplies, Pharmaceutical Research & Development, Specialty Pharmaceuticals

Website

www.aftonscientific.com/

Verticals

Manufacturing

Company Stage

Mature - Buyout

Total Amount Raised

Subscriber access only

Afton Scientific, LLC - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
BuyoutCompletedAfton Scientific, LLC-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.